Continue Reading
Full article on Yahoo Finance
BofA upgrades Moderna after 177% rally driven by cancer vaccine breakthrough
Market Intelligence Analysis
AI-Powered 80% FREE-ANALYSIS-RULE-BASED-ANALYSIS
Why This Matters
Analysis of stock market developments showing bullish sentiment.
Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Investing.com -- Bank of America upgraded Moderna to Neutral with a $170 price objective, following a sharp rally in the stock after positive data on its personalized cancer vaccine, intismeran, in adjuvant melanoma.
AI Breakdown
Summary
Analysis of stock market developments showing bullish sentiment.
Time Horizon
Short Term
Original article published by
Yahoo Finance
on August 20, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.